Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
6 Technological Moats: Developing oral small molecules and high-potency poly-agonists to switch the patient population away from aging peptide assets before generic entry
Retatrutide is still being studied and is not yet approved for general use, which simply means we rely on current data to guide expectations instead of making promises
The GLP-1 pathway plays a pivotal role in regulating blood sugar levels and promoting overall health
Specifications Molecular Formula CHNO Molecular Weight 5302.3 g/mol Receptor Targets GLP-1R + GIPR + GCGR (triple agonist) Form Lyophilized white powder Storage (unopened) -20C, protected from light Storage (reconstituted) 2-8C, use within 30 days Reconstitution & storage Add 2 mL of bacteriostatic water to the 10 mg vial for a 5 mg/mL working concentration
US$ 24.74
US$ 20.17
US$ 20.35
US$ 22.63
US$ 20.14
US$ 26.22
US$ 22.65
US$ 20.02
US$ 27.89
